Delivery Order SPE2DR25D2014-SPE2DR26FZ67F
- Not listed
- The Defense Logistics Agency awarded a $6,904.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $3,266.05 to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units. This is a competitively awarded, non-set-aside contract with firm fixed pricing and a completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single task issued against a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units with a ceiling value of $4,706.55. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract carries no set-aside designation, and performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,182.95 of Naftifine HCL 1% Cream (60GM) with an ultimate completion date of October 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- The Defense Logistics Agency awarded a $1,941.77 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This delivery order, valued at $1,466.22, awards Naftifine HCl 1% cream to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract was awarded on October 31, 2025, with an ultimate completion date of the same day, and utilizes firm fixed price pricing with no set-aside designation. The funding agency is the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceuticals and medical supplies to support military...
- The Defense Logistics Agency awarded a delivery order valued at $3,369.43 to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by October 20, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. Naftifine HCL cream is an antifungal medication commonly used to...
- The Defense Logistics Agency awarded a $128,090 firm fixed price delivery order to AmerisourceBergen Drug Corporation for NAFTIFINE HCL 2% CREAM 45GM. The single award delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and will be performed by AmerisourceBergen in Conshohocken, Pennsylvania between September 8-11, 2023. As a leading provider of pharmaceuticals and medical supplies, AmerisourceBergen will deliver the antifungal skin cream to support...
- The Defense Logistics Agency awarded a $887.51 delivery order to Amerisourcebergen Drug Corporation for NAFTIFINE HCL 1% cream in 60gm quantities. The firm fixed price order calls for delivery to a location in Conshohocken, Pennsylvania by August 15, 2023 to support DLA programs. Amerisourcebergen will serve as the prime contractor to fulfill the requirements on behalf of the Defense Logistics Agency, the logistics combat support agency of the United States Department of Defense, to provide...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ67FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram quantities, with a ceiling value of $2,146.02. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 12, 2025. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical supply vehicle running through December 2026 that serves military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems. As a prime contractor under the DLA Troop Support Medical IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. The company's demonstrated capability to compete successfully in the federal marketplace, combined with its expansive pharmaceutical inventory, positions it to fulfill varied medical supply requirements for military and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/10/25 |